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A B S T R A C T
Tryptophan (TRP) is essential for many physiological processes, and its metabolism changes in some
diseases such as infection and cancer. The most studied aspects of TRP metabolism are the kynurenine
and serotonin pathways. A minor metabolic route, tryptamine and N,N-dimethyltryptamine (DMT)
biosynthesis, has received far less attention, probably because of the very low amounts of these
compounds detected only in some tissues, which has led them to be collectively considered as trace
amines. In a previous study, we showed a metabolic interrelationship for TRP in melanoma cell lines.
Here, we identiﬁed DMT and N,N-dimethyl-N-formyl-kynuramine (DMFK) in the supernatant of cultured
SK-Mel-147 cells. Furthermore, when we added DMT to the cell culture, we found hydroxy-DMT (OH-
DMT) and indole acetic acid (IAA) in the cell supernatant at 24 h. We found that SK-Mel-147 cells
expressed mRNA for myeloperoxidase (MPO) and also had peroxidase activity. We further found that
DMT oxidation was catalyzed by peroxidases. DMT oxidation by horseradish peroxidase, H2O2 and MPO
from PMA-activated neutrophils produced DMFK, N,N-dimethyl-kynuramine (DMK) and OH-DMT.
Oxidation of DMT by peroxidases apparently uses the common peroxidase cycle involving the native
enzyme, compound I and compound II. In conclusion, this study describes a possible alternative
metabolic pathway for DMT involving peroxidases that has not previously been described in humans and
identiﬁes DMT and metabolites in a melanoma cell line. The extension of these ﬁndings to other cell
types and the biological effects of DMT and its metabolites on cell proliferation and function are key
questions for future studies.
 2014 Elsevier Inc. All rights reserved.
Contents lists available at ScienceDirect
Biochemical Pharmacology
jo u rn al h om epag e: ww w.els evier .c o m/lo cat e/b io c hem p har mAbbreviations: AFMK, N-acetyl-N-formyl-5-methoxy-kynuramine; AMK, N-acetyl-
5-metoxy-kynuramine; DMEM, Dulbecco’ modiﬁed eagle medium; DMFK, N,N-
dimethyl-N-formyl-kynuramine; DMK, N,N-dimethyl-quinuramine; DMSO, di-
methyl sulfoxide; DMT, N,N-dimethyltryptamine; DPI, diphenyliodonium; FBS,
fetal bovine serum; H2O2, hydrogen peroxide; HRP, horseradish peroxidase; IAA, 3-
indoleacetic acid; IDO, indoleamine 2,3-dioxygenase; KYN, kynurenine; LC–MS/MS,
liquid chromatography–mass spectrometry; LC–UV-ESI-MS, liquid chromatogra-
phy-UV detection–electrospray ionization-mass spectrometry; MAO-A, mono-
amine oxidase A; MPO, myeloperoxidase; m/z, mass-to-charge ratio; O2
,
superoxide anion; PBS, phosphate-buffered saline; PMA, phorbol 12-myristate
13-acetate; ROS, reactive oxygen species; SOD, superoxide dismutase; TDO,
tryptophan 2,3-dioxygenase; TRP, tryptophan; TRY, tryptamine.
* Corresponding author at: Faculdade de Cieˆncias Farmaceˆuticas, Universidade
de Sa˜o Paulo, CEP 05508-000, Sa˜o Paulo, Brazil. Tel.: +55 11 3091 3741;
fax: +55 11 3813 2197.
E-mail address: anacampa@usp.br (A. Campa).
1 These authors equally contributed to this study.
0006-2952/$ – see front matter  2014 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.bcp.2014.01.0351. Introduction
When not used for protein synthesis, the essential amino acid
tryptophan (TRP) is mainly degraded (95%) through the kynur-
enine (KYN) pathway [1,2]. The ﬁrst and rate-limiting step of this
biochemical process is catalyzed by two dioxygenases: tryptophan
2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO)
[3]. The incorporation of two atoms of oxygen into the TRP indole
ring and the cleavage of this ring generates the indole ring-opening
product N-formyl-kynurenine that is then deformylated to KYN
(Fig. 1A).
Another well-studied route for TRP metabolism is the serotonin
pathway, which is responsible for approximately 4% of TRP
metabolization [4]. Some tissues such as the pineal gland produce
the hormone melatonin from serotonin [5] (Fig. 1B). Although the
KYN and serotonin routes account together for almost all TRP
metabolism, a small amount of TRP is converted into tryptamine
(TRY) and its methylated forms monomethyl-tryptamine and N,N-
Fig. 1. TRP metabolism in humans. (A) Kynurenine (KYN), (B) serotoninergic/melatoninergic and (C) tryptamine (TRY)/dimethyltryptamine (DMT) pathways.
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concentrations in human total blood, urine, feces, lung, kidney and
cerebrospinal ﬂuid, they are collectively known as trace amines [7–
10]. Although trace amines and the enzymes involved in their
biosynthesis from TRP have only been found in few human tissues
and ﬂuids [6,11], information regarding DMT metabolization is
even scarcer. It is known that a portion of DMT is metabolized by
the enzyme monoamine oxidase A (MAO-A) into 3-indoleacetic
acid (IAA), the primary known metabolite [12,13].
One difference among the three aforementioned biochemical
routes of TRP metabolism is that the KYN pathway leads to loss of
the indole moiety, whereas the serotonin pathway and the
production of TRY and DMT preserve it (Fig. 1). The enzymes
TDO and IDO speciﬁcally catalyze TRP indole ring opening and do
not act on other indolic compounds [14]. However, previous
studies have shown that KYN can also be generated by TRP
degradation catalyzed by different peroxidases [15,16], including
neutrophil myeloperoxidase (MPO).
Furthermore, peroxidases are not speciﬁc and act on different
indolic compounds, leading to products that have an indole
opening ring mark analogous to KYN. For example, melatonin
metabolization by MPO forms N1-acetyl-N2-formyl-5-metoxy-
kynuramine (AFMK) and the demethylated form N1-acetyl-5-
metoxy-kynuramine (AMK) (Fig. 2) [15,16]. The biological rele-
vance of KYN and KYN-like compounds is clear; KYN is a pivotal
molecule for immune escape by tumors with resulting tolerance
[17], and AFMK and AMK have shown several immunomodulatory
effects [18,19].
Based on the information above and on the preliminary ﬁnding
that SK-Mel-147 produced DMT, we studied DMT metabolizationFig. 2. Melatonin oxidation to indole ring-opening products. N1-acetyl-N2-formyby peroxidases, including MPO, that are present in neutrophils, and
decided to search for possible DMT metabolites, including indole
ring-opened molecules, that could be associated with the presence
of peroxidases in the SK-Mel-147 melanoma line.
2. Materials and methods
2.1. Reagents and solutions
Horseradish peroxidase (HRP) type VI (EC number 1.11.1.7),
dextran, Histopaque1-1077, phorbol 12-myristate 13-acetate
(PMA), catalase (EC 1.11.1.6), superoxide dismutase (SOD) (EC
1.15.1.1), 5-amino-2,3dihydro-1,4-phthalazinedione (luminol),
tryptamine (TRY), dichloromethane, indole, sodium and ammoni-
um formate, and diphenyliodonium (DPI) were purchased from
Sigma–Aldrich (St Louis, MO, USA). Dimethyl sulfoxide (DMSO),
sodium azide, D-glucose, KH2PO4, NaCl, Na2HPO412 H2O, 29%
H2O2, KCl, CaCl2, MgCl2, ammonium acetate, formic acid, HPLC-
grade acetonitrile, hexane, ethyl acetate and methanol were
purchased from Merck (Darmstadt, Germany). All other reagents
used were of analytical grade. Dulbecco’ Modiﬁed Eagle Medium
(DMEM), fetal bovine serum (FBS) and penicillin (50 U/mL) –
streptomycin (50 mg/mL) solution were purchased from Gibco
(Grand Island, NY, USA).
Stock solutions of PMA were prepared in DMSO (100 mM) and
stored at 20 8C. Phosphate-buffered saline (PBS) solution (10 mM,
pH 7.4) was prepared using 10 mM KCl and 140 mM NaCl. In
experiments with neutrophils, 1.0 mM CaCl2, 0.5 mM MgCl2, and
1.0 mg/mL D-glucose were added to PBS (this complete buffer is
referred to as Buffer A).l-5-metoxy-kynuramine (AFMK); N1-acetyl-5-methoxykynuramine (AMK).
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Because of the absence of a commercial standard for DMT, it
was synthesized from TRY according to Bosch et al. [20] and
puriﬁed by semipreparative normal-phase liquid chromatography
using Shimadzu Prominence (Kyoto, Japan) equipment. Separation
was achieved on a Luna Silica column (250 mm  10 mm, 5 mm;
Phenomenex, CA, USA) under isocratic elution employing hexane
and ethyl acetate (65:35) as the mobile phase and run at 4 mL/min.
The column efﬂuent was monitored at 200–400 nm using a diode
array detector (SPDM20A). Fractions of interest were collected
(FRC-10A), concentrated in a rotary evaporator (Buchi,
Switzerland) and further characterized by electrospray ionization
mass spectrometry (Esquire HCT, Bruker Daltonics, MA, USA).
2.3. Melanoma cell line SK-Mel-147 culture
The melanoma cell line SK-Mel-147 was grown in DMEM high-
glucose medium supplemented with 10% FBS and penicillin (50 U/
mL) – streptomycin (50 mg/mL) and maintained at 37 8C under a
5% CO2 atmosphere. Cells were plated on 6-well plates and grown
for 24 h until they reached 80% conﬂuence.
2.4. Identiﬁcation of DMT and its metabolites in SK-Mel-147 by LC–
MS/MS
An indole solution in methanol (100 mL at 100 mg/mL) was
added to the cultured cell supernatants as an internal control. Cold
dichloromethane (1:2.5) was then added, and the mixture was
vortexed for 3 min continuously. The tubes were centrifuged at
10,621  g for 10 min, and the organic phase was transferred to a
glass tube protected from light and dried under nitrogen gas ﬂow.
To reconstitute samples, 150 mL of a solution containing acetoni-
trile:4 mM ammonium formate (50:50) was added, and the tubes
were vortexed for 1 min and centrifuged in a Spin-X centrifuge
tube with a 22-mm ﬁlter (Costar, Corning, USA) for 5 min at
239  g. The supernatant (20 mL) was analyzed by LC–MS/MS.
The products found in the supernatants were separated on a
Kinetex C18 column (50 mm  4.6 mm, 2.6 mm; Phenomenex,
Torrance, CA, USA) coupled to a KrudKatcher ultra column in-line
ﬁlter (Phenomenex) at a ﬂow rate of 0.35 mL/min under gradient
elution using 4 mM ammonium formate pH 4 (solvent A) and
0.01% formic acid in acetonitrile (solvent B) as the mobile phase.
The elution gradient was as follows: (i) 0–1 min (50:50), (ii) 1–
6.5 min (0:100), and (iii) 6.5–9 min (50:50). We used a 320 MS
triple quadrupole mass spectrometer (Varian, USA) with an
electrospray ionization (ESI) source, which was operated in the
positive mode.
Using a Workstation 6.9 data analysis system (Varian, USA), the
data were collected in multiple reaction monitoring mode by
selecting the transition m/z 189 (M+H)+ > 58 for DMT, m/z 118
(M+H)+ > 90 [21] for the internal standard, and 12 V as the
collision energy. All of the conditions were optimized by analysis of
a standard 1.0 mg/mL DMT solution.
2.5. Real-time PCR and analysis of peroxidase activity for MPO
Total RNA was extracted from cells using an RNeasy Mini kit
(Qiagen). Contaminating genomic DNA was removed using the
RNase-free DNase Data Set (Qiagen). Up to 1 mg of total RNA was
reverse transcribed using the High-capacity RNA-to-cDNA kit
(Applied Biosystems). Real-time PCR was performed using the
TaqMan ﬂuorescence energy transfer assay on an ABI Prism 7500
Sequence Detection System (Applied Biosystems). The primers and
ﬂuorogenic probe were from Applied Biosystems [codes
Hs00266705_g1 (GAPDH) and Hs00924295_m1 (MPO)]. Therelative comparison method (2DDCT) was used to compare the
mRNA expression levels.
Peroxidase activity was estimated in a microplate luminometer
(LB96V – EG&G Berthold). Luminol (1.0 mM) and H2O2 (0.5 mM) in
PBS pH 7.4 were added to cell homogenates prepared from 1  106
cells at 37 8C.
2.6. Analysis of DMT reaction products by LC–UV-ESI-MS
DMT reaction products were separated on a Synergi Polar-RP
column (250 mm  4.6 mm, 4 mm; Phenomenex, Torrance, CA,
USA) at a ﬂow rate of 1.0 mL/min under gradient elution using
10 mM ammonium acetate + 0.01% formic acid (solvent A) and
acetonitrile (solvent B) as the mobile phase. The column efﬂuent
was monitored at 288 nm using a diode array detector (SPD-
M20A, Shimadzu Prominence, Kyoto, Japan) before being applied
to an Esquire HCT iontrap mass spectrometer (Bruker Daltonics,
Billerica, MA, USA). A ﬂow divisor was used to divert 0.2 mL/min to
the electrospray ionization (ESI) source, which was operated in
the positive mode with a 3.5 kV capillary sprayer voltage.
Nitrogen was used as the nebulizer (35 psi) and drying gas (5.0 L/
min, 300 8C). Helium was used as the buffer and collision gas.
High-resolution mass spectrometry experiments for elemental
composition conﬁrmation were performed on a time-of-ﬂight
(TOF) mass spectrometer (MicroTOF, Bruker Daltonics, Billerica,
MA, USA).
2.7. Oxidation of DMT by HRP/H2O2 system
DMT (0.1 mM) was incubated with 1.0 mM HRP and 0.5 mM
H2O2 in PBS (pH 7.4) in a ﬁnal volume of 300 mL under agitation
(850 rpm) in a thermomixer (Eppendorf, Edison, NJ, USA) with light
protection at 37 8C. The reaction was stopped after 60 min by
adding 300 mL of ice-cold acetonitrile. The sample was centrifuged
at 9600  g for 5 min, and 20 mL of the supernatant was analyzed
by LC–UV-ESI-MS.
2.8. Isolation of human neutrophils
Puriﬁed neutrophils (98%) were obtained from healthy blood
donors by Histopaque1-1077 centrifugation, dextran sedimenta-
tion, and hypotonic lysis of red blood cells [22]. After isolation,
neutrophils were resuspended in 1.0 mL of Buffer A, and cell
density was determined in a Neubauer improved bright-line
chamber. Blood collection was performed according to a protocol
approved by the Faculty Ethical Committee at University of Sa˜o
Paulo (CEP/FCF no. 109/2007).
2.9. Oxidation of DMT by activated neutrophils
Neutrophils (2.0  106 cells/assay) were stimulated by addition
of 50 ng/mL PMA at 37 8C in Buffer A under smooth and constant
agitation (350 rpm) in the dark. After 5 min, DMT (0.1 mM) was
added to a ﬁnal volume of 300 mL. Aliquots were taken at speciﬁc
times and mixed with 300 mL of ice-cold acetonitrile to stop the
reaction. Samples were centrifuged at 9600  g for 5 min, and
20 mL of the supernatant was analyzed by LC–UV-ESI-MS.
2.10. Reaction of DMT with activated neutrophils and addition of
reactive oxygen scavengers and enzyme inhibitors
Catalase (10 mg/assay), SOD (10 mg/assay), azide (1.0 mM) and
DPI (20 mM) were preincubated with neutrophils (2.0  106 cells/
mL) in 10 mM Buffer A (pH 7.4) for 5 min. After this period, cells
were stimulated with 50 ng/mL PMA, and 0.1 mM DMT was added
to a ﬁnal volume of 300 mL. The systems were incubated under
Fig. 3. Tryptamine metabolites in SK-Mel-147 cells. Although TRY was not detected (ND) in the cell culture supernatant, DMT and DMFK were identiﬁed by LC–MS/MS. DMFK,
OH-DMT and IAA were also identiﬁed after addition of 100 mM DMT to the cell culture. The data are the mean of three independent experiments with CV bellow 15%. Data are
presented as the ratio of the metabolite to the internal standard. All compounds were detected below the limits of quantiﬁcation.
Fig. 4. MPO mRNA expression and peroxidase activity in SK-Mel-147 cells. (A) MPO
mRNA was expressed in SK-Mel-147 cells, and its expression was not modiﬁed by
the addition of 100 mM TRY or DMT in cell culture. (B) Peroxidase activity was
measured in the SK-Mel-147 cell homogenate (1.0  106 cells) in the presence of
luminol (1.0 mM) and H2O2 (0.5 mM). Data are shown as relative luminescence
units (RLU). The error bars correspond to the SEM from three independent
experiments.
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the reactions were stopped by addition of 300 mL of ice-cold
acetonitrile. Cells were pelleted by centrifugation (9600  g for
5 min), and the supernatants were analyzed by LC–UV-ESI-MS.
2.11. Statistics
Statistical signiﬁcance of differences in the mean values of all
experimental groups was calculated using a one-way ANOVA.
P < 0.05 was considered to be statistically signiﬁcant.
3. Results
3.1. Identiﬁcation of DMT and its metabolites in human melanoma
cell cultures
SK-Mel-147 is a cell line derived from metastatic melanoma,
and it was chosen for this study because we recently showed that
the two main TRP metabolic pathways, that is, the KYN and
serotoninergic pathways, are active in this line [23]. No previous
data are available on the presence of DMT in this or other cell lines.
In this study, we used LC–MS/MS to identify DMT and its precursor
TRY in 24 h supernatants of cell cultures. IAA, a known metabolite
of the TRY/DMT pathway, was also sought. Commercial TRY, DMT
and IAA were used to optimize the LC–MS/MS analysis conditions.
Using standardized conditions, we searched for the following three
other potential products of DMT: N,N-dimethyl-N-formyl-kynur-
amine (DMFK), N,N-dimethyl-kynuramine (DMK) and OH-DMT.
Given the lack of commercial standards for DMFK, DMK and OH-
DMT, we based our search on fragmentation parameters for these
compounds as described in the Materials and Methods. Surpris-
ingly, DMT and DMFK were detected in as early as 24 h in cell
culture supernatants extracted with dichloromethane. When
0.1 mM DMT was incubated with cultured cells for 24 h, OH-
DMT and IAA were also detected (Fig. 3). TRY was not detected
under any conditions.
3.2. Peroxidase activity of SK-Mel-147
Although it was previously thought that MPO was exclusive to
phagocytes, it is currently recognized that other cell types express
it [24,25]. Because DMFK was detected in SK-Mel-147 cells, we
investigated MPO mRNA expression. SK-Mel-147 cells expressed
MPO mRNA as shown by qPCR, and the levels of expression were
not changed by the addition of TRY or DMT (Fig. 4A). We estimated
the peroxidase activity in SK-Mel-147 cells by the luminol-
chemiluminescent assay (Fig. 4B), as peroxidases catalyze the
chemiluminescent oxidation of luminol by H2O2 [26]. The higherlevel of light was in the presence of SK-Mel-147 cell homogenates
than in the control reactions indicates the presence of an active
peroxidase in this cell type.
3.3. Oxidation of DMT by the HRP/H2O2 system and identiﬁcation of
DMT metabolites
Indole ring-opening products are formed from indole com-
pounds by reaction with reactive oxygen species in non-enzymatic
pathways or in dioxygenase- or peroxidase-catalyzed reactions
Fig. 5. HPLC analysis of DMT oxidation by HRP/H2O2. DMT (0.1 mM) was incubated
with HRP (1.0 mM) and H2O2 (0.5 mM). UV chromatogram of DMT at 288 nm (A) at
time zero; and (B) after 15 min of reaction when it was stopped by addition of one
volume (300 mL) of ice-cold acetonitrile.
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TDO is very speciﬁc for tryptophan, and IDO is not able to oxidize
DMT [14]. However, peroxidases have been shown to be very
effective in the formation of indole ring-opening products [15].
Myeloperoxidase (MPO) is the most abundant peroxidase in
humans, especially in neutrophils [28].
Based on our previous studies showing that indole ring
compounds are oxidized by peroxidases to products analogous
to kynurenine [15], we studied the oxidation of DMT by two
frequently used peroxidase systems: horseradish peroxidase
(HRP)/H2O2 and activated human neutrophils. HRP is commercial-
ly available and is extensively used as a peroxidase model in kinetic
and mechanistic studies. The addition of H2O2 to the native
enzyme leads to the formation of compound I, which is active and
capable of oxidizing different molecules, such as TRP [27] and
melatonin [15,16]. Indole ring-opening products are observed in
the oxidation of both molecules. The consumption of DMT and the
generation of new peaks were observed by LC/UV analysis and
were totally dependent on the addition of HRP and H2O2 (Fig. 5A
and B). From the HPLC analysis, we were able to further
characterize peaks 1 and 2. The products were identiﬁed by LC/
MS-MS; the m/z 189 signal and other three ions, m/z 205
(corresponding to peak 1), m/z 221 (corresponding to peak 2)
and m/z 193, correspond to DMT.
Fragmentation analyses of the m/z 205 ion (Fig. 6A) showed the
same proﬁle for the known hallucinogens bufotenin (5-OH-DMT)and psilocin (4-OH-DMT) [29]. Because in our experiment it was
not possible to identify the real position of the hydroxyl group on
the aromatic ring, it was generically named OH-DMT. MS/MS
analyses of ion m/z 221 showed a neutral loss of dimethylamine
(C2H7N) and dimethylethylamine (C4H11N), and the m/z 193 ion
(loss of CO) was also detected. This result suggests that this
compound was an indole ring-opened DMT, designated here as
DMFK (Fig. 6B). The m/z 193 ion showed the same neutral loss of
DMT, OH-DMT and DMFK, and the spectrum indicated the
presence of the deformylated form of DMFK, DMK (Fig. 6C). The
elemental composition of these three DMT metabolites were
conﬁrmed by high-resolution mass spectrometry (Micro TOF) by
direct injection after HPLC separation (Fig. 7A and B).
3.4. Reaction of DMT with activated neutrophils
Neutrophils have two important features that characterize
them as a good biochemical system for peroxidase-catalyzed
reactions. When activated, neutrophils organize the NADPH
oxidase system to ensure an adequate supply of superoxide
anion (O2
) and H2O2 [30,31]. Furthermore, they are the cells
with the highest level of MPO [32]. Neutrophils can be activated
by physiological and non-physiological stimuli. Here, we used
the non-physiological stimulus phorbol myristate acetate (PMA).
Similar to what was observed in the presence of HRP/H2O2, PMA-
activated neutrophils oxidized DMT to OH-DMT, DMFK and
DMK. Because of the relatively low yield of the reaction, the
products were analyzed only by iontrap mass spectrometry and
conﬁrmed by high resolution MicroTOF (Fig. 5). The kinetics of
DMT consumption and the products formed are presented in
Fig. 8.
As in previous studies on the oxidation of melatonin [15] and
lysergic acid diethylamide [33] by activated neutrophils, various
inhibitors were added to neutrophils to establish the mechanism
by which the cells form DMFK and OH-DMT (Fig. 9). The
production of DMFK and OH-DMT was almost abolished when
NADPH oxidase was inhibited by diphenyliodonium (DPI), show-
ing that superoxide and/or H2O2 must be produced by neutrophils
before they can oxidize DMT. Azide, an inhibitor of MPO,
profoundly affected DMFK and OH-DMT production, thus empha-
sizing the need for an active peroxidase to oxidize DMT.
In terms of the response to reactive oxygen species scavengers,
DMFK production was affected more by superoxide dismutase
(SOD) than OH-DMT (72% versus 43% inhibition). SOD has a
stronger inhibitory action than catalase on the formation of DMFK.
However, the production of OH-DMT was not affected by the
addition of catalase [34].
The formation of both products identiﬁed here, DMFK and OH-
DMT, may occur through a peroxidase cycle that includes
tryptophan [27], melatonin [15,16] and LSD [33]. Compound I of
the peroxidases reacts with DMT to generate the radical DMT,
which reacts with molecular oxygen or the superoxide anion to
create a dioxetane intermediate that is cleaved to produce DMFK.
The hydroxylated product could be formed by an alternative
pathway involving the compound III (Fig. 10) [34].
4. Discussion
Biochemical and toxicological studies with trace amines have
attracted attention because of their numerous effects on cognition,
perception, satiety, and its possible participation in psychiatric [6]
and neurodegenerative disorders [35,36], and even in the social/
religious framework utilizing hallucinogenic drinks prepared from
plants rich in these compounds, such as Ayahuasca tea. In this
study, we describe an alternative metabolic pathway for DMT that
has not been previously identiﬁed in human cells. DMT-OH, DMFK
Fig. 6. Fragmentation spectra (MS/MS) of the metabolites of the DMT/HRP/H2O2 reaction. (A) m/z 205 ion (OH-DMT), (B) m/z 221 ion (DMFK) and (C) m/z 193 ion (DMK). The
ESI was operated in positive mode.
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reactions, suggesting a role for peroxidases or peroxidase-like
enzyme activities in DMT metabolization. Furthermore, we
detected DMT and DMFK in the supernatant of a melanoma cell
line. The signiﬁcance of this ﬁnding is not yet known, but it is
apparent that DMT is present in a previously unsuspected variety
of cells.
In recent years, knowledge of the storage, receptors and
metabolism of DMT has increased. Riba et al. [37] measured DMT
metabolites in volunteers who received DMT orally and concluded
that oxidative deamination of DMT by MAO may not be the sole
metabolic pathway in humans. In vitro and animal studies have
found endogenous psychedelic tryptamines in humans [38] and
also found tryptamine metabolites in the pineal gland [39]. In
addition to DMT, 5-hydroxy-DMT (bufotenin, HDMT) and 5-
methoxy-DMT (MDMT) have been reported as endogenous
substances in humans. Mcllhenny et al. [40] described N-oxidation,
N-demethylation and cyclization as alternative DMT metabolic
routes. Full characterization of DMT metabolites is required for cell
biochemical and biology studies and also from pharmacological
and toxicological points of view given the increasing interest in the
potential medical applications of Ayahuasca [41]. This study
addressed whether DMFK and DMT-OH are representative or
minor metabolites of DMT in vivo. The presence of DMFK, but not
IAA, in the supernatants of cultured melanoma cells under basalconditions suggests that DMFK may be a central DMT metabolite,
at least for some cell types.
Another aspect that deserves to be considered is the possibility
that the hallucinogenic activity of DMT, either endogenously
produced or ingested, may be correlated with its oxidation by
peroxidases, because hydroxylated compounds such as psilocin
and/or bufotenin, which are known hallucinogens, are formed. It is
interesting that DMT has been related to schizophrenia [42,43],
and bufotenin was found in the urine of patients with schizophre-
nia and other mental illnesses [44,45]. DMT and psilocin have been
shown to have anxiolytic activity [6,46].
Chemically, the metabolic pathway described here is similar to
that described for other natural indolic compounds such as MLT
[15], TRP [48] and SER [49], and for the hallucinogen lysergic acid
diethylamide [33]. The common characteristic of the peroxidase-
catalyzed oxidation of these indolic compounds is the indole ring-
opening similar to the products formed by the action of the enzyme
indolamine 2,3 dioxygenase. However neither MLT [47] nor DMT
[14] seems to be IDO substrates. Products from the metabolism of
TRP have been described as neuroprotectants and neurotoxins.
Indole ring-opening products formed from TRP and MLT, i.e., KYN
and AFMK, respectively, have a strong effect on the immune
system. KYN plays a central role in tolerance [17,50], and AFMK/
AMK is implicated in immune regulation [19]. DMT metabolization
by peroxidases may thus be relevant in homeostasis, and especially
Fig. 7. Mass spectra (micro TOF) of the metabolites of the DMT/HRP/H2O2 reaction. (A) m/z 205 ion (OH-DMT) and (B) m/z 221 ion (DMFK). The ESI was operated in positive
mode. Relative error in the micro TOF analysis was below 2 ppm.
Fig. 8. Kinetics of DMT consumption and formation of metabolites by activated neutrophils. PMA (50 ng/mL)-activated neutrophils (6.0  106 cells/assay) were incubated
with DMT (0.1 mM). After 15, 30, 45 or 60 min the reactions were stopped by the addition of one volume (300 mL) of ice-cold acetonitrile. Compounds were analyzed by LC–
MS/MS. The data at 60 min are the mean  SD of three independent experiments.
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Fig. 9. Effects of reactive oxygen species scavengers on OH-DMT and DMFK produced from DMT by PMA-activated neutrophils. Catalase (10 mg/assay), azide (1.0 mM), SOD
(10 mg/assay) and DPI (20 mM/assay) were added to PMA (50 ng/ml)-activated neutrophils (2.0  106 cells/assay) in the presence of DMT (0.1 mM). The OH-DMT and DMFK
metabolites were analyzed by LC–MS/MS. The data represent the integrated area of the peaks after a 15-min reaction and are presented as the mean  SD of ﬁve experiments.
Fig. 10. Proposed mechanism for oxidation of DMT catalyzed by peroxidases. DMFK
and DMK are hypothetically formed from a dioxetane intermediate.
M.M. Gomes et al. / Biochemical Pharmacology 88 (2014) 393–401400in diseases in which inﬂammation is present. Peroxidase activity is
broadly found in tissues and cells, and in inﬂammatory conditions.
Neutrophils, monocytes and macrophages may thus provide a
source of peroxidases.
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